Centessa Pharmaceuticals plc (CNTA) › Operating Cash FlowCentessa Pharmaceuticals plc (CNTA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$5.83M2020: -$10.63M2022: -$200.55M2023: -$160.34M2024: -$142.06M2025: -$193.82M-$193.82M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$193.82M-36.4%2024-$142.06M+11.4%2023-$160.34M+20.0%2022-$200.55M—2020-$10.63M-82.5%2019-$5.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share